Darunavir/ritonavir monotherapy in clinical practice

被引：1
|
作者：
Parienti, Jean-Jacques [1 ,2 ,3 ]
机构：
[1] Caen Cote de Nacre Univ Hosp, Dept Infect Dis & Clin Res & Biostat, Caen, France
[2] Univ Paris 06, Paris, France
[3] INSERM, UMR S 707, Paris, France
来源：
AIDS | 2011年 / 25卷 / 01期
关键词：
INDINAVIR;
D O I：
10.1097/QAD.0b013e3283405d2c
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [31] Switching to darunavir/ritonavir monotherapy (DRV/r mx): effect on kidney function and lipid profile
    Martinez-Colubi, M.
    Perez Elias, M.
    Sanz, J.
    Gomez, C.
    Estrada, V
    Sepulveda, M.
    Moreno, A.
    Muriel, A.
    Carranza, M.
    De Palacio, M.
    Dronda, F.
    Gomez-Ayerbe, C.
    Casado, J.
    Moreno, S.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2012, 15 : 162 - 162
  • [32] The fate of ritonavir in the presence of darunavir
    Nguyen, D. N.
    Van den Mooter, G.
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2014, 475 (1-2) : 214 - 226
  • [33] Refining criteria for selecting candidates for a safe lopinavir/ritonavir or darunavir/ritonavir monotherapy in HIV-infected virologically suppressed patients
    Gianotti, Nicola
    Cozzi-Lepri, Alessandro
    Antinori, Andrea
    Castagna, Antonella
    De Luca, Andrea
    Celesia, Benedetto Maurizio
    Galli, Massimo
    Mussini, Cristina
    Pinnetti, Carmela
    Spagnuolo, Vincenzo
    Monforte, Antonella d'Arminio
    Ceccherini-Silberstein, Francesca
    Andreoni, Massimo
    PLOS ONE, 2017, 12 (02):
  • [34] Analysis of drug resistance during HIV RNA viraemia in the MONET trial of darunavir/ritonavir monotherapy
    Pulido, Federico
    Arribas, Jose R.
    Hill, Andrew
    Van Delft, Yvon
    Moecklinghoff, Christione
    ANTIVIRAL THERAPY, 2011, 16 (01) : 59 - 65
  • [35] Budget impact analysis of switching to darunavir/ritonavir monotherapy for HIV-infected people in Spain
    Juan Pasquau
    Joana Gostkorzewicz
    Francisco Ledesma
    Anne Anceau
    Andrew Hill
    Christiane Moecklinghoff
    Applied Health Economics and Health Policy, 2012, 10 (2) : 139 - 141
  • [36] Early lipid changes with atazanavir/ritonavir or darunavir/ritonavir
    Martinez, E.
    Gonzalez-Cordon, A.
    Ferrer, E.
    Domingo, P.
    Negredo, E.
    Gutierrez, F.
    Portilla, J.
    Curran, A.
    Podzamczer, D.
    Murillas, J.
    Bernardino, J. I.
    Santos, I.
    Carton, J. A.
    Peraire, J.
    Pich, J.
    Perez, I.
    Gatell, J. M.
    HIV MEDICINE, 2014, 15 (06) : 330 - 338
  • [37] Influence of monotherapy with darunavir-ritonavir on semen quality and on the presence of HIV in the semen of HIV plus patients
    Clavero, A.
    Navas, P.
    Gonzalvo, M.
    Lopez Regalado, M.
    Sanchez, I.
    Guzman, A.
    Martinez-Granados, L.
    Gutierrez, H.
    Navarrete, M.
    Romero, B.
    Rodriguez, I.
    Pasquau, J.
    Javier-Martinez, R.
    Rus, M. A.
    Castilla, J. A.
    HUMAN REPRODUCTION, 2016, 31 : 162 - 163
  • [38] Cellular HIV reservoir replenishment is not affected by blip or intermittent viremia episodes during darunavir/ritonavir monotherapy
    Torres-Cornejo, Almudena
    BenMarzouk-Hidalgo, Omar J.
    Gutierrez-Valencia, Alicia
    Perez-Romero, Pilar
    Martin-Pena, Reyes
    Ruiz-Valderas, Rosa
    Viciana, Pompeyo
    Lopez-Cortes, Luis F.
    AIDS, 2014, 28 (02) : 201 - 208
  • [39] Factors Associated With Virological Failure in HIV-1-Infected Patients Receiving Darunavir/Ritonavir Monotherapy
    Lambert-Niclot, Sidonie
    Flandre, Philippe
    Valantin, Marc-Antoine
    Peytavin, Gilles
    Duvivier, Claudine
    Haim-Boukobza, Stephanie
    Algarte-Genin, Michele
    Yazdanpanah, Yazdan
    Girard, Pierre-Marie
    Katlama, Christine
    Calvez, Vincent
    Marcelin, Anne-Genevieve
    JOURNAL OF INFECTIOUS DISEASES, 2011, 204 (08): : 1211 - 1216
  • [40] Resistance mutations in protease gene at baseline are not related to virological failure in patients treated with darunavir/ritonavir monotherapy
    Gutierrez-Liarte, Angela
    Gomez-Berrocal, Ana
    Saez, Carmen
    Valencia, Jorge
    Santos, Ignacio
    Sanz, Jesus
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2014, 17 : 163 - 163
12345